Snowden Capital Advisors LLC Danaher Corp Transaction History

Snowden Capital Advisors LLC

$3.29 Billion
Q3 2024

A detailed history of Snowden Capital Advisors LLC transactions in Danaher Corp stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 9,970 shares of DHR stock, worth $2.35 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

9,970

Previous 9,894 0.77%

Holding current value

$2.35 Million

Previous $2.47 Million 12.1%

% of portfolio

0.08%

Previous 0.07%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$239.25 - $280.76 $18,183 - $21,337	76 Added 0.77%	9,970 $2.77 Million
Q2 2024 Aug 14, 2024	SELL	$235.51 - $267.98 $66,884 - $76,106	-284 Reduced 2.79%	9,894 $2.47 Million
Q1 2024 May 15, 2024	BUY	$224.58 - $256.19 $369,209 - $421,176	1,644 Added 19.26%	10,178 $2.54 Million
Q4 2023 Feb 14, 2024	BUY	$185.1 - $233.13 $293,568 - $369,744	1,586 Added 22.83%	8,534 $1.97 Million
Q3 2023 Nov 14, 2023	SELL	$233.08 - $265.59 $83,209 - $94,815	-357 Reduced 4.89%	6,948 $1.72 Million
Q2 2023 Aug 14, 2023	SELL	$224.99 - $256.14 $133,644 - $152,147	-594 Reduced 7.52%	7,305 $1.75 Million
Q1 2023 May 15, 2023	SELL	$239.75 - $277.0 $73,843 - $85,316	-308 Reduced 3.75%	7,899 $1.99 Million
Q4 2022 Feb 13, 2023	SELL	$241.42 - $282.29 $106,466 - $124,489	-441 Reduced 5.1%	8,207 $2.18 Million
Q3 2022 Nov 09, 2022	SELL	$247.06 - $1507.4 $92,647 - $565,275	-375 Reduced 4.16%	8,648 $2.23 Million
Q2 2022 Aug 12, 2022	BUY	$237.11 - $299.66 $86,308 - $109,076	364 Added 4.2%	9,023 $2.29 Million
Q1 2022 May 16, 2022	BUY	$257.27 - $315.76 $1.45 Million - $1.78 Million	5,626 Added 185.49%	8,659 $2.54 Million
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $885,878 - $997,887	3,033 New	3,033 $998,000
Q3 2021 Feb 05, 2024	BUY	$272.21 - $332.43 $518,287 - $632,946	1,904 Added 27.4%	8,852 $2.69 Billion
Q2 2021 Jan 08, 2024	BUY	$225.08 - $271.69 $803,760 - $970,204	3,571 Added 71.18%	8,588 $2.3 Billion
Q1 2021 Jan 08, 2024	BUY	$212.38 - $245.9 $219,176 - $253,768	1,032 Added 25.9%	5,017 $1.13 Billion
Q4 2020 Jan 08, 2024	BUY	$212.5 - $245.46 $2,337 - $2,700	11 Added 0.28%	3,985 $885 Million
Q3 2020 Jan 08, 2024	BUY	$177.16 - $215.33 $9,035 - $10,981	51 Added 1.3%	3,974 $856 Million
Q2 2020 Jan 08, 2024	BUY	$128.7 - $176.83 $29,086 - $39,963	226 Added 6.11%	3,923 $694 Million
Q1 2020 Jan 08, 2024	BUY	$121.39 - $169.05 $54,261 - $75,565	447 Added 13.75%	3,697 $512 Million
Q4 2019 Jan 30, 2024	BUY	$133.47 - $153.48 $1,735 - $1,995	13 Added 0.4%	3,250 $499 Million
Q4 2019 Jan 08, 2024	BUY	$133.47 - $153.48 $1,735 - $1,995	13 Added 0.4%	3,250 $499 Million
Q3 2019 Jan 30, 2024	SELL	$135.4 - $146.47 $1,354 - $1,464	-10 Reduced 0.31%	3,237 $468 Million
Q3 2019 Jan 08, 2024	SELL	$135.4 - $146.47 $5.56 Million - $6.01 Million	-41,033 Reduced 92.69%	3,237 $468 Million
Q2 2019 Jan 30, 2024	SELL	$124.88 - $143.73 $462,180 - $531,944	-3,701 Reduced 53.27%	3,247 $464 Million
Q2 2019 Jan 08, 2024	BUY	$124.88 - $143.73 $5.09 Million - $5.86 Million	40,765 Added 1163.05%	44,270 $465 Million
Q1 2019 Jan 08, 2024	BUY	$97.62 - $132.29 $2,342 - $3,174	24 Added 0.69%	3,505 $463 Million
Q4 2018 Jan 08, 2024	BUY	$94.85 - $109.54 $14,132 - $16,321	149 Added 4.47%	3,481 $359 Million
Q3 2018 Jan 08, 2024	BUY	$98.13 - $108.9 $47,691 - $52,925	486 Added 17.08%	3,332 $362 Million
Q2 2018 Jan 08, 2024	BUY	$96.1 - $103.24 $8,937 - $9,601	93 Added 3.38%	2,846 $281 Million
Q1 2018 Jan 08, 2024	BUY	$92.16 - $103.8 $2,304 - $2,595	25 Added 0.92%	2,753 $270 Million
Q4 2017 Jan 08, 2024	BUY	$85.26 - $94.62 $2,898 - $3,217	34 Added 1.26%	2,728 $253 Million
Q3 2017 Jan 08, 2024	SELL	$79.29 - $88.45 $337,299 - $376,266	-4,254	2,694 $231 Million

Others Institutions Holding DHR

# of Institutions

2,508

Shares Held

542M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Account

Snowden Capital Advisors LLC Danaher Corp Transaction History